Lab77 Peptides is not affiliated with the cited publications or databases.
The BELIEVE trial was a randomized, double-blind, placebo-controlled Phase 2 study evaluating the effects of semaglutide, bimagrumab, and their combination over 48 weeks, with a 24-week open-label extension
Takeyama Y, Ogino K, Segawa H, Kobayashi H, Uda T, Houbara T
That does not mean every claim is impossible
Each serving provides effective doses of evidence-based ingredients like Capsimax cayenne pepper extract, high-potency green tea leaf extract, caffeine, and more
Medical weight management with GLP-1 medications For weight management, FDA-approved GLP-1 medications, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), have changed what is possible